← Unusual insider activity · Company hub
JNJ Johnson & Johnson
Insider figures are trailing 90 days, open-market Form 4 only. Institutional figures are the latest reported quarter. These windows are not simultaneous.
-$67.8M net selling - trailing 90 days
0 buyers - 5 unique sellers
Historical context: most recent complete month (2026-09) is the 23rd percentile of this ticker's monthly net P/S flow over 24 complete months. Lower percentiles are more selling; higher are more buying. P10–P90: -$24.5M to $0.
Institutional activity: not available - insufficient comparable institutions for the latest complete quarter.
open-market Form 4 only - grants, exercises, tax withholding excluded. ~ derived from SEC-reported shares x price.
Institutional activity: not available - insufficient comparable institutions for the latest complete quarter.
Who is responsible
| Insider | Role | Net activity | Rows |
|---|---|---|---|
| Duato Joaquin | CEO and Chairman of the Board | -~$44.7M | 4 |
| Schmid Timothy | EVP, WW Chair, MedTech | -~$9.2M | 2 |
| Broadhurst Vanessa | EVP, Global Corp Affairs | -~$5.8M | 1 |
| Forminard Elizabeth | EVP, Chief Legal Officer | -~$4.1M | 2 |
| Taubert Jennifer L | EVP, WWC. Innovative Medicine | -~$4.0M | 1 |
Transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| September 2, 2026 | Schmid Timothy | EVP, WW Chair, MedTech | 2 reported sale rows | 33597 | — | ~$9.2M |
| September 2, 2026 | Schmid Timothy | EVP, WW Chair, MedTech | S | -22527 | 274.74 | ~$6.2M |
| September 2, 2026 | Schmid Timothy | EVP, WW Chair, MedTech | S | -11070 | 274.74 | ~$3.0M |
| August 17, 2026 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | S | -15000 | 263.36 | ~$4.0M |
| August 13, 2026 | Duato Joaquin | CEO and Chairman of the Board | 2 reported sale rows | 123291 | — | ~$32.2M |
| August 13, 2026 | Duato Joaquin | CEO and Chairman of the Board | S | -102315 | 261 | ~$26.7M |
| August 13, 2026 | Duato Joaquin | CEO and Chairman of the Board | S | -20976 | 262 | ~$5.5M |
| August 6, 2026 | Forminard Elizabeth | EVP, Chief Legal Officer | 2 reported sale rows | 15918 | — | ~$4.1M |
| August 6, 2026 | Forminard Elizabeth | EVP, Chief Legal Officer | S | -9344 | 257.755 | ~$2.4M |
| August 6, 2026 | Forminard Elizabeth | EVP, Chief Legal Officer | S | -6574 | 255.932 | ~$1.7M |
| August 5, 2026 | Duato Joaquin | CEO and Chairman of the Board | 2 reported sale rows | 48480 | — | ~$12.5M |
| August 5, 2026 | Duato Joaquin | CEO and Chairman of the Board | S | -6523 | 258.739 | ~$1.7M |
| August 5, 2026 | Duato Joaquin | CEO and Chairman of the Board | S | -41957 | 258.056 | ~$10.8M |
| July 20, 2026 | Broadhurst Vanessa | EVP, Global Corp Affairs | S | -23054 | 251.266 | ~$5.8M |
| June 11, 2026 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | S | -10000 | 241.15 | ~$2.4M |
| February 27, 2026 | Decker Robert J | VP Corporate Controller | S | -4075 | 247.87 | ~$1.0M |
| February 20, 2026 | Schmid Timothy | EVP, WW Chair, MedTech | S | -1322 | 245.66 | ~$0.3M |
| February 18, 2026 | Schmid Timothy | EVP, WW Chair, MedTech | 2 reported sale rows | 22623 | — | ~$5.5M |
| February 18, 2026 | Schmid Timothy | EVP, WW Chair, MedTech | S | -8998 | 244.53 | ~$2.2M |
| February 18, 2026 | Schmid Timothy | EVP, WW Chair, MedTech | S | -13625 | 244.2 | ~$3.3M |
| February 17, 2026 | REED JOHN C | EVP, Innovative Medicine, R&D | 3 reported sale rows | 53931 | — | ~$13.1M |
| February 17, 2026 | REED JOHN C | EVP, Innovative Medicine, R&D | S | -21721 | 243 | ~$5.3M |
| February 17, 2026 | REED JOHN C | EVP, Innovative Medicine, R&D | S | -2283 | 243 | ~$0.6M |
| February 17, 2026 | REED JOHN C | EVP, Innovative Medicine, R&D | S | -29927 | 243 | ~$7.3M |
| February 17, 2026 | Swanson James D. | EVP, CIO | S | -20521 | 242.7 | ~$5.0M |
| February 17, 2026 | Wolk Joseph J | Exec VP, CFO | 4 reported sale rows | 89654 | — | ~$21.8M |
| February 17, 2026 | Wolk Joseph J | Exec VP, CFO | S | -19241 | 242.99 | ~$4.7M |
| February 17, 2026 | Wolk Joseph J | Exec VP, CFO | S | -24961 | 242.68 | ~$6.1M |
| February 17, 2026 | Wolk Joseph J | Exec VP, CFO | S | -33386 | 242.75 | ~$8.1M |
| February 17, 2026 | Wolk Joseph J | Exec VP, CFO | S | -12066 | 242.87 | ~$2.9M |
| February 17, 2026 | Broadhurst Vanessa | EVP, Global Corp Affairs | S | -6197 | 243.39 | ~$1.5M |
| February 13, 2026 | Swanson James D. | EVP, CIO | 2 reported sale rows | 41559 | — | ~$10.1M |
| February 13, 2026 | Swanson James D. | EVP, CIO | S | -22191 | 243.71 | ~$5.4M |
| February 13, 2026 | Swanson James D. | EVP, CIO | S | -19368 | 243.76 | ~$4.7M |
| January 26, 2026 | Duato Joaquin | CEO and Chairman of the Board | 2 reported sale rows | 100000 | — | ~$22.1M |
| January 26, 2026 | Duato Joaquin | CEO and Chairman of the Board | S | -51218 | 220.986 | ~$11.3M |
| January 26, 2026 | Duato Joaquin | CEO and Chairman of the Board | S | -48782 | 221.484 | ~$10.8M |
| November 26, 2025 | MORIKIS JOHN G | — | P | 1250 | 206.15 | ~$0.3M |
| October 17, 2025 | REED JOHN C | EVP, Innovative Medicine, R&D | S | -21721 | 192.7072 | ~$4.2M |
| September 4, 2025 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | S | -56471 | 177.806 | ~$10.0M |
| August 22, 2025 | Duato Joaquin | CEO and Chairman of the Board | S | -125824 | 179.2079 | ~$22.5M |
| August 15, 2025 | Wolk Joseph J | Exec VP, CFO | S | -16820 | 176.9067 | ~$3.0M |
| July 17, 2025 | REED JOHN C | EVP, Innovative Medicine, R&D | S | -19137 | 163.5486 | ~$3.1M |
| February 25, 2025 | Decker Robert J | VP Corporate Controller | S | -6999 | 165.88 | ~$1.2M |
| February 18, 2025 | Schmid Timothy | EVP, WW Chair, MedTech | S | -403 | 156.15 | ~$63K |
| February 7, 2025 | Wolk Joseph J | Exec VP, CFO | S | -13015 | 153.89 | ~$2.0M |
| December 12, 2024 | WEINBERGER MARK A | — | P | 1000 | 147.22 | ~$0.1M |